LinkedIn post Isologic goes electric

🔌Isologic Goes Electric!

We are excited to announce the expansion of our electric fleet with the addition of the Mercedes-Benz eCitan. This compact and sustainable vehicle boasts a range of approximately 280km and can be rapidly charged from 20% to 80% ursing fast-charging stations. 

Our commitment to electric mobility is driven by our collaboration with Radboud Translational Medicine B.V., where we transport medical isotopes daily to healthcare facilities both domestically and internationally. Furthermore, many of our clients are increasingly seeking sustainable logistics solutions. With the implementation of zero-emission zones in cities such as Nijmegen, and the expectation that more cities will follow this example, this is a significant step forward.

At Isologic, delivery reliability is paramount: it is crucial that hospitals receive the necessary medical sources on time for patient treatment. The Mercedes-Benz eCitan supports us in this mission with its dependable performance and swift charging capabilities.

A notable feature of this eCitan is its specialized software that optimizes temperature settings for efficient charging. We will now rigorously test the performance and reliability of this electric van, as we previously did with an electric FIAT Doblo. Interested in the results? Please contact us: https://lnkd.in/et8ny4EK

#Isologic hashtag#ElectricDriving hashtag#Sustainability hashtag#Logistics hashtag#Healthcare hashtag#ZeroEmission

LinkedIn post Isologic goes electric

Ander nieuws

Eerste leverkankerpatiënt behandeld met microbolletjes bestraald in TU Delft

Eerste leverkankerpatiënt behandeld met microbolletjes bestraald in TU Delft

Radboud Translational Medicine gaat de uitvulling van onderstaand product verzorgen, zie ook: https:...

Lees meer

First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer

First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer

The below product is manufactured at RTM First Patient Dosed in Phase II Study of TLX250-CDx in Tri...

Lees meer

ABX heeft een handelsvergunning ontvangen voor Radelumin® in Duitsland

ABX heeft een handelsvergunning ontvangen voor Radelumin® in Duitsland

ABX heeft een vergunning ontvangen voor het in de handel brengen van de radiotracer Radelumin® in Du...

Lees meer

Production of novel diagnostic radionuclides in small medical cyclotrons

Production of novel diagnostic radionuclides in small medical cyclotrons

Medewerkers van RTM en het Radboudumc hebben een nieuw artikel gepubliceerd: 'Production of novel di...

Lees meer

Geïnteresseerd in een samenwerking?

Neem contact met ons op om de mogelijkheden te bespreken.